Latest news from Montefiore Einstein Cancer Center on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/test35/?sc=rsin /articles/test35/?sc=rsin Wed, 08 May 2024 14:00:00 EST Researchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) have shown that a breakthrough therapy for treating blood cancers can be adapted to treat solid tumors--an advance that could transform cancer treatment. The promising findings, reported today in Science Advances, involve CAR-T cell therapy, which supercharges the immune system to identify and attack cancer cells. Montefiore Einstein Cancer Center /articles/new-test-shows-promise-for-detecting-hard-to-find-cervical-cancers/?sc=rsin /articles/new-test-shows-promise-for-detecting-hard-to-find-cervical-cancers/?sc=rsin Thu, 07 Sep 2023 00:05:00 EST In findings with potentially important implications for cervical cancer screening, scientists at the National Cancer Institute (NCI)-designated Montefiore Einstein Cancer Center (MECC) have developed a test for detecting a type of cervical cancer that Pap tests often miss. The findings published online today in the Journal of the National Cancer Institute (JNCI). Montefiore Einstein Cancer Center /articles/montefiore-einstein-cancer-center-awarded-2-9m-nci-calabresi-training-award/?sc=rsin /articles/montefiore-einstein-cancer-center-awarded-2-9m-nci-calabresi-training-award/?sc=rsin Wed, 07 Jun 2023 10:00:36 EST The National Cancer Institute (NCI)-designated Montefiore Einstein Cancer Center (MECC) has received a five-year, $2.9 million grant from the NCI to train physicians and scientists to conduct clinical and translational oncology research, with a special emphasis on investigating and addressing health inequities in the Bronx. The funding, part of the Paul Calabresi Career Development Award for Clinical Oncology (PCACO), will support up to four scholars for two to three years. Montefiore Einstein Cancer Center /articles/a-simple-antibacterial-treatment-solves-a-severe-skin-problem-caused-by-radiation-therapy/?sc=rsin /articles/a-simple-antibacterial-treatment-solves-a-severe-skin-problem-caused-by-radiation-therapy/?sc=rsin Thu, 04 May 2023 11:00:00 EST Acute radiation dermatitis (ARD)--characterized by red, sore, itchy or peeling skin--affects up to 95% of people undergoing radiation treatment for cancer. Severe cases can cause significant swelling and painful skin ulcers that can severely impair quality of life, yet little is known about why this condition occurs and no standardized treatments for preventing severe ARD have been widely adapted. Montefiore Einstein Cancer Center /articles/montefiore-einstein-cancer-center-receives-10-million-grant-to-study-lung-metastasis-in-breast-cancer/?sc=rsin /articles/montefiore-einstein-cancer-center-receives-10-million-grant-to-study-lung-metastasis-in-breast-cancer/?sc=rsin Mon, 19 Sep 2022 12:55:09 EST The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), has awarded Jonathan Backer, M.D., professor and chair of molecular pharmacology at Albert Einstein College of Medicine and associate director for shared resources at Montefiore Einstein Cancer Center (MECC), a five-year, $10 million team science (P01) grant to investigate the mechanisms regulating cancer cells that seed tumors in the lungs, a key metastatic site for breast cancer. Montefiore Einstein Cancer Center